GSK3α levels in Alzheimer´s disease mimicking models
- Published on 01/29/2025
- Reading time: 4 min.
Beatriz Pinho , Margarida Vaz , Tânia Soares Martins , Odete da Cruz e Silva , Ana Gabriela Henriques
Neurosciences and Signalling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro Portugal
Abstract
Background Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by the development of amyloid plaques and neurofibrillary tangles in the brain, which contribute to synaptic dysfunction and extensive neuronal loss. Protein phosphorylation is a key event in AD pathogenesis. Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase with two isoforms, GSK3α and GSK3β. While GSK3β link with AD is well stablished, the role...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Neurology
Receive our newsletter to stay up to date with the latest news in Neurology